nodes	percent_of_prediction	percent_of_DWPC	metapath
Ioflupane I 123—Increased appetite—Nateglinide—type 2 diabetes mellitus	0.0198	0.0205	CcSEcCtD
Ioflupane I 123—Increased appetite—Rosiglitazone—type 2 diabetes mellitus	0.0162	0.0168	CcSEcCtD
Ioflupane I 123—Neoplasm malignant—Gliclazide—type 2 diabetes mellitus	0.0149	0.0154	CcSEcCtD
Ioflupane I 123—Increased appetite—Pioglitazone—type 2 diabetes mellitus	0.0136	0.0141	CcSEcCtD
Ioflupane I 123—Increased appetite—Glimepiride—type 2 diabetes mellitus	0.0133	0.0137	CcSEcCtD
Ioflupane I 123—Immune system disorder—Linagliptin—type 2 diabetes mellitus	0.0124	0.0129	CcSEcCtD
Ioflupane I 123—Immune system disorder—Acarbose—type 2 diabetes mellitus	0.0121	0.0125	CcSEcCtD
Ioflupane I 123—Malnutrition—Linagliptin—type 2 diabetes mellitus	0.012	0.0124	CcSEcCtD
Ioflupane I 123—Immune system disorder—Nateglinide—type 2 diabetes mellitus	0.0117	0.012	CcSEcCtD
Ioflupane I 123—Malnutrition—Nateglinide—type 2 diabetes mellitus	0.0112	0.0116	CcSEcCtD
Ioflupane I 123—Vertigo—Tolazamide—type 2 diabetes mellitus	0.0109	0.0112	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Miglitol—type 2 diabetes mellitus	0.0104	0.0108	CcSEcCtD
Ioflupane I 123—Immune system disorder—Repaglinide—type 2 diabetes mellitus	0.0101	0.0104	CcSEcCtD
Ioflupane I 123—Increased appetite—Gliclazide—type 2 diabetes mellitus	0.00982	0.0101	CcSEcCtD
Ioflupane I 123—Malnutrition—Repaglinide—type 2 diabetes mellitus	0.00972	0.01	CcSEcCtD
Ioflupane I 123—Immune system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00953	0.00984	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Tolbutamide—type 2 diabetes mellitus	0.00939	0.00969	CcSEcCtD
Ioflupane I 123—Malnutrition—Rosiglitazone—type 2 diabetes mellitus	0.00919	0.00949	CcSEcCtD
Ioflupane I 123—Increased appetite—Orlistat—type 2 diabetes mellitus	0.00892	0.00921	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Chlorpropamide—type 2 diabetes mellitus	0.00854	0.00882	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Tolazamide—type 2 diabetes mellitus	0.00854	0.00882	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Linagliptin—type 2 diabetes mellitus	0.00845	0.00873	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Acarbose—type 2 diabetes mellitus	0.0082	0.00847	CcSEcCtD
Ioflupane I 123—Immune system disorder—Pioglitazone—type 2 diabetes mellitus	0.00799	0.00825	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Nateglinide—type 2 diabetes mellitus	0.00791	0.00817	CcSEcCtD
Ioflupane I 123—Immune system disorder—Sitagliptin—type 2 diabetes mellitus	0.00776	0.00801	CcSEcCtD
Ioflupane I 123—Increased appetite—Irbesartan—type 2 diabetes mellitus	0.00775	0.00801	CcSEcCtD
Ioflupane I 123—Malnutrition—Pioglitazone—type 2 diabetes mellitus	0.0077	0.00795	CcSEcCtD
Ioflupane I 123—Malnutrition—Glimepiride—type 2 diabetes mellitus	0.0075	0.00775	CcSEcCtD
Ioflupane I 123—Malnutrition—Sitagliptin—type 2 diabetes mellitus	0.00748	0.00772	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00735	0.00759	CcSEcCtD
Ioflupane I 123—Vertigo—Glipizide—type 2 diabetes mellitus	0.00722	0.00746	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00721	0.00745	CcSEcCtD
Ioflupane I 123—Nausea—Miglitol—type 2 diabetes mellitus	0.00718	0.00742	CcSEcCtD
Ioflupane I 123—Paraesthesia—Repaglinide—type 2 diabetes mellitus	0.00712	0.00735	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.007	0.00723	CcSEcCtD
Ioflupane I 123—Vertigo—Pioglitazone—type 2 diabetes mellitus	0.00692	0.00715	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.00685	0.00707	CcSEcCtD
Ioflupane I 123—Headache—Tolbutamide—type 2 diabetes mellitus	0.00681	0.00703	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00675	0.00697	CcSEcCtD
Ioflupane I 123—Vertigo—Sitagliptin—type 2 diabetes mellitus	0.00672	0.00694	CcSEcCtD
Ioflupane I 123—Dysgeusia—Bromocriptine—type 2 diabetes mellitus	0.00663	0.00685	CcSEcCtD
Ioflupane I 123—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00654	0.00675	CcSEcCtD
Ioflupane I 123—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00654	0.00675	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.00647	0.00668	CcSEcCtD
Ioflupane I 123—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00646	0.00667	CcSEcCtD
Ioflupane I 123—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.00625	0.00645	CcSEcCtD
Ioflupane I 123—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.00623	0.00643	CcSEcCtD
Ioflupane I 123—Headache—Chlorpropamide—type 2 diabetes mellitus	0.0062	0.0064	CcSEcCtD
Ioflupane I 123—Headache—Tolazamide—type 2 diabetes mellitus	0.0062	0.0064	CcSEcCtD
Ioflupane I 123—Malnutrition—Glyburide—type 2 diabetes mellitus	0.00619	0.00639	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.00617	0.00637	CcSEcCtD
Ioflupane I 123—Headache—Linagliptin—type 2 diabetes mellitus	0.00613	0.00633	CcSEcCtD
Ioflupane I 123—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.00608	0.00628	CcSEcCtD
Ioflupane I 123—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00606	0.00626	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.00599	0.00618	CcSEcCtD
Ioflupane I 123—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.00589	0.00608	CcSEcCtD
Ioflupane I 123—Nausea—Tolazamide—type 2 diabetes mellitus	0.00588	0.00607	CcSEcCtD
Ioflupane I 123—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00588	0.00607	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00584	0.00603	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.00567	0.00585	CcSEcCtD
Ioflupane I 123—Nausea—Acarbose—type 2 diabetes mellitus	0.00564	0.00583	CcSEcCtD
Ioflupane I 123—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.00564	0.00582	CcSEcCtD
Ioflupane I 123—Pain—Glipizide—type 2 diabetes mellitus	0.00561	0.00579	CcSEcCtD
Ioflupane I 123—Malnutrition—Gliclazide—type 2 diabetes mellitus	0.00556	0.00574	CcSEcCtD
Ioflupane I 123—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.0055	0.00568	CcSEcCtD
Ioflupane I 123—Nausea—Nateglinide—type 2 diabetes mellitus	0.00544	0.00562	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00543	0.0056	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.00542	0.00559	CcSEcCtD
Ioflupane I 123—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.0053	0.00547	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.00529	0.00546	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00527	0.00544	CcSEcCtD
Ioflupane I 123—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.00523	0.00541	CcSEcCtD
Ioflupane I 123—Pain—Sitagliptin—type 2 diabetes mellitus	0.00522	0.00539	CcSEcCtD
Ioflupane I 123—Malnutrition—Valsartan—type 2 diabetes mellitus	0.00511	0.00527	CcSEcCtD
Ioflupane I 123—Malnutrition—Orlistat—type 2 diabetes mellitus	0.00504	0.00521	CcSEcCtD
Ioflupane I 123—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.005	0.00516	CcSEcCtD
Ioflupane I 123—Headache—Repaglinide—type 2 diabetes mellitus	0.00497	0.00513	CcSEcCtD
Ioflupane I 123—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.00496	0.00512	CcSEcCtD
Ioflupane I 123—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00496	0.00512	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00495	0.00511	CcSEcCtD
Ioflupane I 123—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.00494	0.0051	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00483	0.00499	CcSEcCtD
Ioflupane I 123—Immune system disorder—Metformin—type 2 diabetes mellitus	0.00482	0.00498	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00477	0.00493	CcSEcCtD
Ioflupane I 123—Nausea—Repaglinide—type 2 diabetes mellitus	0.00471	0.00487	CcSEcCtD
Ioflupane I 123—Headache—Rosiglitazone—type 2 diabetes mellitus	0.0047	0.00485	CcSEcCtD
Ioflupane I 123—Malnutrition—Metformin—type 2 diabetes mellitus	0.00465	0.0048	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00463	0.00478	CcSEcCtD
Ioflupane I 123—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.00463	0.00478	CcSEcCtD
Ioflupane I 123—Vertigo—Valsartan—type 2 diabetes mellitus	0.00459	0.00474	CcSEcCtD
Ioflupane I 123—Dysgeusia—Metformin—type 2 diabetes mellitus	0.00455	0.0047	CcSEcCtD
Ioflupane I 123—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.00455	0.0047	CcSEcCtD
Ioflupane I 123—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00454	0.00468	CcSEcCtD
Ioflupane I 123—Vertigo—Orlistat—type 2 diabetes mellitus	0.00453	0.00468	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00451	0.00466	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.0045	0.00464	CcSEcCtD
Ioflupane I 123—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00445	0.0046	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00445	0.00459	CcSEcCtD
Ioflupane I 123—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.00439	0.00453	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00436	0.0045	CcSEcCtD
Ioflupane I 123—Dizziness—Glipizide—type 2 diabetes mellitus	0.00434	0.00448	CcSEcCtD
Ioflupane I 123—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.0043	0.00444	CcSEcCtD
Ioflupane I 123—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00425	0.00439	CcSEcCtD
Ioflupane I 123—Dry mouth—Orlistat—type 2 diabetes mellitus	0.0042	0.00434	CcSEcCtD
Ioflupane I 123—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00416	0.00429	CcSEcCtD
Ioflupane I 123—Headache—Glipizide—type 2 diabetes mellitus	0.00411	0.00425	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00409	0.00422	CcSEcCtD
Ioflupane I 123—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00407	0.00421	CcSEcCtD
Ioflupane I 123—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00405	0.00418	CcSEcCtD
Ioflupane I 123—Dysgeusia—Losartan—type 2 diabetes mellitus	0.00404	0.00418	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00404	0.00417	CcSEcCtD
Ioflupane I 123—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00404	0.00417	CcSEcCtD
Ioflupane I 123—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00394	0.00407	CcSEcCtD
Ioflupane I 123—Headache—Pioglitazone—type 2 diabetes mellitus	0.00394	0.00407	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00392	0.00404	CcSEcCtD
Ioflupane I 123—Nausea—Glipizide—type 2 diabetes mellitus	0.0039	0.00403	CcSEcCtD
Ioflupane I 123—Pain—Gliclazide—type 2 diabetes mellitus	0.00388	0.004	CcSEcCtD
Ioflupane I 123—Headache—Glimepiride—type 2 diabetes mellitus	0.00384	0.00396	CcSEcCtD
Ioflupane I 123—Headache—Sitagliptin—type 2 diabetes mellitus	0.00382	0.00395	CcSEcCtD
Ioflupane I 123—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00374	0.00386	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00372	0.00384	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00372	0.00384	CcSEcCtD
Ioflupane I 123—Vertigo—Losartan—type 2 diabetes mellitus	0.00371	0.00383	CcSEcCtD
Ioflupane I 123—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.0037	0.00382	CcSEcCtD
Ioflupane I 123—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00367	0.00379	CcSEcCtD
Ioflupane I 123—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00365	0.00377	CcSEcCtD
Ioflupane I 123—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00365	0.00377	CcSEcCtD
Ioflupane I 123—Nausea—Glimepiride—type 2 diabetes mellitus	0.00364	0.00376	CcSEcCtD
Ioflupane I 123—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00363	0.00374	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.0036	0.00371	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00355	0.00367	CcSEcCtD
Ioflupane I 123—Malnutrition—Ramipril—type 2 diabetes mellitus	0.00354	0.00366	CcSEcCtD
Ioflupane I 123—Pain—Orlistat—type 2 diabetes mellitus	0.00352	0.00364	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00351	0.00363	CcSEcCtD
Ioflupane I 123—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.00347	0.00358	CcSEcCtD
Ioflupane I 123—Headache—Bromocriptine—type 2 diabetes mellitus	0.00346	0.00357	CcSEcCtD
Ioflupane I 123—SLC6A3—Dopaminergic Neurogenesis—NKX6-1—type 2 diabetes mellitus	0.00345	0.113	CbGpPWpGaD
Ioflupane I 123—Dry mouth—Losartan—type 2 diabetes mellitus	0.00344	0.00355	CcSEcCtD
Ioflupane I 123—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00341	0.00352	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00334	0.00345	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.0033	0.00341	CcSEcCtD
Ioflupane I 123—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00328	0.00339	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00328	0.00338	CcSEcCtD
Ioflupane I 123—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00322	0.00332	CcSEcCtD
Ioflupane I 123—SLC6A3—Dopaminergic Neurogenesis—NEUROD1—type 2 diabetes mellitus	0.00321	0.105	CbGpPWpGaD
Ioflupane I 123—Vertigo—Ramipril—type 2 diabetes mellitus	0.00318	0.00328	CcSEcCtD
Ioflupane I 123—Headache—Glyburide—type 2 diabetes mellitus	0.00316	0.00327	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00309	0.00319	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00307	0.00317	CcSEcCtD
Ioflupane I 123—Pain—Irbesartan—type 2 diabetes mellitus	0.00306	0.00316	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00303	0.00313	CcSEcCtD
Ioflupane I 123—Paraesthesia—Losartan—type 2 diabetes mellitus	0.00303	0.00312	CcSEcCtD
Ioflupane I 123—Nausea—Glyburide—type 2 diabetes mellitus	0.003	0.0031	CcSEcCtD
Ioflupane I 123—Dizziness—Gliclazide—type 2 diabetes mellitus	0.003	0.0031	CcSEcCtD
Ioflupane I 123—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00295	0.00304	CcSEcCtD
Ioflupane I 123—Pain—Losartan—type 2 diabetes mellitus	0.00288	0.00298	CcSEcCtD
Ioflupane I 123—Headache—Gliclazide—type 2 diabetes mellitus	0.00284	0.00293	CcSEcCtD
Ioflupane I 123—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.00283	0.00293	CcSEcCtD
Ioflupane I 123—Dizziness—Valsartan—type 2 diabetes mellitus	0.00276	0.00285	CcSEcCtD
Ioflupane I 123—Dizziness—Orlistat—type 2 diabetes mellitus	0.00272	0.00281	CcSEcCtD
Ioflupane I 123—Nausea—Gliclazide—type 2 diabetes mellitus	0.00269	0.00278	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00264	0.00272	CcSEcCtD
Ioflupane I 123—Headache—Valsartan—type 2 diabetes mellitus	0.00261	0.0027	CcSEcCtD
Ioflupane I 123—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.00259	0.00268	CcSEcCtD
Ioflupane I 123—Headache—Orlistat—type 2 diabetes mellitus	0.00258	0.00266	CcSEcCtD
Ioflupane I 123—Dizziness—Metformin—type 2 diabetes mellitus	0.00251	0.00259	CcSEcCtD
Ioflupane I 123—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.00249	0.00258	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00248	0.00256	CcSEcCtD
Ioflupane I 123—Nausea—Valsartan—type 2 diabetes mellitus	0.00247	0.00256	CcSEcCtD
Ioflupane I 123—Nausea—Orlistat—type 2 diabetes mellitus	0.00245	0.00253	CcSEcCtD
Ioflupane I 123—Headache—Metformin—type 2 diabetes mellitus	0.00238	0.00245	CcSEcCtD
Ioflupane I 123—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00237	0.00245	CcSEcCtD
Ioflupane I 123—Nausea—Metformin—type 2 diabetes mellitus	0.00225	0.00233	CcSEcCtD
Ioflupane I 123—Headache—Irbesartan—type 2 diabetes mellitus	0.00224	0.00232	CcSEcCtD
Ioflupane I 123—Dizziness—Losartan—type 2 diabetes mellitus	0.00223	0.0023	CcSEcCtD
Ioflupane I 123—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00213	0.0022	CcSEcCtD
Ioflupane I 123—Nausea—Irbesartan—type 2 diabetes mellitus	0.00213	0.0022	CcSEcCtD
Ioflupane I 123—SLC6A3—Alpha-synuclein signaling—GRK5—type 2 diabetes mellitus	0.00211	0.0689	CbGpPWpGaD
Ioflupane I 123—Headache—Losartan—type 2 diabetes mellitus	0.00211	0.00218	CcSEcCtD
Ioflupane I 123—Nausea—Losartan—type 2 diabetes mellitus	0.002	0.00207	CcSEcCtD
Ioflupane I 123—Dizziness—Ramipril—type 2 diabetes mellitus	0.00191	0.00197	CcSEcCtD
Ioflupane I 123—Headache—Ramipril—type 2 diabetes mellitus	0.00181	0.00187	CcSEcCtD
Ioflupane I 123—Nausea—Ramipril—type 2 diabetes mellitus	0.00172	0.00177	CcSEcCtD
Ioflupane I 123—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.000986	0.0321	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Monoamine Transport—NOS1—type 2 diabetes mellitus	0.000946	0.0308	CbGpPWpGaD
Ioflupane I 123—Cocaine—CYP3A4—type 2 diabetes mellitus	0.000936	1	CrCbGaD
Ioflupane I 123—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.000776	0.0253	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000747	0.0244	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—SLC5A4—type 2 diabetes mellitus	0.000711	0.0232	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000671	0.0219	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—KCNK16—type 2 diabetes mellitus	0.000634	0.0207	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Monoamine Transport—AGT—type 2 diabetes mellitus	0.000618	0.0201	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—SLC5A2—type 2 diabetes mellitus	0.000539	0.0176	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.00051	0.0166	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000448	0.0146	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—KCNQ1—type 2 diabetes mellitus	0.00044	0.0143	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000433	0.0141	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—ABCC2—type 2 diabetes mellitus	0.000424	0.0138	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.00038	0.0124	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000379	0.0124	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—SLC2A2—type 2 diabetes mellitus	0.000368	0.012	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000353	0.0115	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Alpha-synuclein signaling—SRC—type 2 diabetes mellitus	0.000344	0.0112	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000341	0.0111	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000339	0.0111	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Parkinsons Disease Pathway—CASP3—type 2 diabetes mellitus	0.000336	0.0109	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000333	0.0109	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Dopaminergic Neurogenesis—TGFB1—type 2 diabetes mellitus	0.000316	0.0103	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—GAD2—type 2 diabetes mellitus	0.000291	0.0095	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000289	0.00941	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—SLC2A1—type 2 diabetes mellitus	0.000285	0.00929	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Monoamine Transport—TNF—type 2 diabetes mellitus	0.00028	0.00913	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000279	0.00909	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—SLC2A4—type 2 diabetes mellitus	0.000273	0.00891	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000263	0.00859	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000245	0.00799	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	0.000238	0.00775	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—HMOX1—type 2 diabetes mellitus	0.000234	0.00764	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000232	0.00756	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000228	0.00742	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000221	0.00722	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.00022	0.00717	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.00022	0.00717	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—GSTM1—type 2 diabetes mellitus	0.000218	0.00712	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000216	0.00705	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—AGER—type 2 diabetes mellitus	0.000211	0.00687	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000201	0.00655	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000188	0.00612	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000183	0.00597	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.00018	0.00586	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000179	0.00584	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000179	0.00584	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000172	0.00562	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000172	0.00562	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000172	0.00561	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000169	0.00552	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000163	0.00532	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000157	0.00511	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000147	0.00478	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000146	0.00477	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000142	0.00462	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—GNB3—type 2 diabetes mellitus	0.00014	0.00457	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.00014	0.00457	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000136	0.00443	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000132	0.0043	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000125	0.00408	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000118	0.00384	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000113	0.00367	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000113	0.00367	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.00011	0.00358	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000109	0.00356	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000109	0.00354	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—CALM1—type 2 diabetes mellitus	0.000107	0.0035	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000101	0.00329	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	9.57e-05	0.00312	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	9.13e-05	0.00298	CbGpPWpGaD
Ioflupane I 123—SLC6A3—NRF2 pathway—TGFB1—type 2 diabetes mellitus	8.9e-05	0.0029	CbGpPWpGaD
Ioflupane I 123—SLC6A3—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	8.87e-05	0.00289	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	8.75e-05	0.00285	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	7.54e-05	0.00246	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	7.51e-05	0.00245	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	7.44e-05	0.00243	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	7.19e-05	0.00234	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	6.72e-05	0.00219	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	6.07e-05	0.00198	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.69e-05	0.00185	CbGpPWpGaD
Ioflupane I 123—SLC6A3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.51e-05	0.00147	CbGpPWpGaD
